PortalPublikationenFirst-line treatment of pancreatic cancer patients with the ...

First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.

Standard

First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group. / Pelzer, Uwe; Arnold, Dirk; Reitzig, Peter; Herrenberger, Julia; Korsten, Friedrich Wilhelm; Kindler, Manfred; Stieler, Jens; Dörken, Bernd; Riess, Hanno; Oettle, Helmut.

in: CANCER CHEMOTH PHARM, Jahrgang 68, Nr. 5, 5, 2011, S. 1173-1178.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Pelzer, U, Arnold, D, Reitzig, P, Herrenberger, J, Korsten, FW, Kindler, M, Stieler, J, Dörken, B, Riess, H & Oettle, H 2011, 'First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.', CANCER CHEMOTH PHARM, Jg. 68, Nr. 5, 5, S. 1173-1178. <http://www.ncbi.nlm.nih.gov/pubmed/21400239?dopt=Citation>

APA

Pelzer, U., Arnold, D., Reitzig, P., Herrenberger, J., Korsten, F. W., Kindler, M., Stieler, J., Dörken, B., Riess, H., & Oettle, H. (2011). First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group. CANCER CHEMOTH PHARM, 68(5), 1173-1178. [5]. http://www.ncbi.nlm.nih.gov/pubmed/21400239?dopt=Citation

Vancouver

Pelzer U, Arnold D, Reitzig P, Herrenberger J, Korsten FW, Kindler M et al. First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group. CANCER CHEMOTH PHARM. 2011;68(5):1173-1178. 5.

Bibtex

@article{804ab111facb4303b283da1c3d120554,
title = "First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.",
abstract = "This open-label, multi-center phase II study investigated the efficacy and safety of the combination of 5-fluorouracil (5-FU)/folinic acid (FA) plus gemcitabine (GFF) in patients with advanced pancreatic cancer. The study is based on our completed dose finding phase I trial.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Survival Analysis, Leucovorin/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use, Fluorouracil/administration & dosage, Deoxycytidine/administration & dosage/analogs & derivatives, Pancreatic Neoplasms/*drug therapy, Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Survival Analysis, Leucovorin/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use, Fluorouracil/administration & dosage, Deoxycytidine/administration & dosage/analogs & derivatives, Pancreatic Neoplasms/*drug therapy",
author = "Uwe Pelzer and Dirk Arnold and Peter Reitzig and Julia Herrenberger and Korsten, {Friedrich Wilhelm} and Manfred Kindler and Jens Stieler and Bernd D{\"o}rken and Hanno Riess and Helmut Oettle",
year = "2011",
language = "English",
volume = "68",
pages = "1173--1178",
journal = "CANCER CHEMOTH PHARM",
issn = "0344-5704",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.

AU - Pelzer, Uwe

AU - Arnold, Dirk

AU - Reitzig, Peter

AU - Herrenberger, Julia

AU - Korsten, Friedrich Wilhelm

AU - Kindler, Manfred

AU - Stieler, Jens

AU - Dörken, Bernd

AU - Riess, Hanno

AU - Oettle, Helmut

PY - 2011

Y1 - 2011

N2 - This open-label, multi-center phase II study investigated the efficacy and safety of the combination of 5-fluorouracil (5-FU)/folinic acid (FA) plus gemcitabine (GFF) in patients with advanced pancreatic cancer. The study is based on our completed dose finding phase I trial.

AB - This open-label, multi-center phase II study investigated the efficacy and safety of the combination of 5-fluorouracil (5-FU)/folinic acid (FA) plus gemcitabine (GFF) in patients with advanced pancreatic cancer. The study is based on our completed dose finding phase I trial.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Survival Analysis

KW - Leucovorin/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use

KW - Fluorouracil/administration & dosage

KW - Deoxycytidine/administration & dosage/analogs & derivatives

KW - Pancreatic Neoplasms/drug therapy

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Survival Analysis

KW - Leucovorin/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use

KW - Fluorouracil/administration & dosage

KW - Deoxycytidine/administration & dosage/analogs & derivatives

KW - Pancreatic Neoplasms/drug therapy

M3 - SCORING: Journal article

VL - 68

SP - 1173

EP - 1178

JO - CANCER CHEMOTH PHARM

JF - CANCER CHEMOTH PHARM

SN - 0344-5704

IS - 5

M1 - 5

ER -